Drawing for NAMUPLEX

USPTO serial 79407609

NAMUPLEX

Reviewed by CopyMark Law Group

Reg. 7895446Status 700Registered
Filing date
Status date
Registration date
Aug 19, 2025
Examiner
LAM, HAI-LY HUYNH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NAMUPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sang Yoon Kang

Sang Yoon Kang Studebaker Brackett PLLC8255 Greensboro DriveSuite 300Tysons, VA 22102

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for medical and veterinary use; diagnostic reagents for medical or veterinary use; diagnostic reagents for medical use; diagnostic reagents for pharmaceutical use; clinical diagnostic reagents for medical use; medical diagnostic reagents for immunological diseases; diagnostic agents for medical or veterinary use; reagents and media for medical and veterinary diagnosis; diagnostic agents for medical and veterinary use; medical pregnancy diagnostic reagents and assays for testing body fluids; medical diagnostic agents for use in the detection, treatment, and monitoring of cancer, genetic diseases, genetic predispositions, and drug responses; diagnostic reagents for in vitro medical use; chemical reagents for medical diagnosis and analysis; chemical diagnostic agents for medical purposes used by medical laboratories; medical diagnostic agents for use in the analysis and monitoring of tumors; medical diagnostic test reagents for use in the analysis and monitoring of tumors; reagents for medical purposes, namely, for the treatment, monitoring, or diagnosis of diseases; diagnostic radiopharmaceutical preparations and reagents for the medical analysis and identification of nucleic acids, nucleic acid sequences, infectious agents, and pathogens; culture media for cultivating animal cells for veterinary use; culture media for use in blood analysis for medical purposes; cell culture media for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Apr 9, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 26, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 23, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 23, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 5, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 5, 2026FIMPFINAL DISPOSITION PROCESSED—
Nov 19, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 19, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 19, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 3, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 3, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 28, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 5, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 5, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 5, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 5, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 29, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 29, 2025RFRRREFUSAL PROCESSED BY MPU—
Feb 24, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 23, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2025DOCKASSIGNED TO EXAMINER—
Oct 25, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 25, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance